{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T15:13:21Z","timestamp":1794755601501,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Wellcome Trust (Pathfinder Award), the Midven Rainbow Seed Fund, Quethera Ltd, University of Cambridge Enterprise, the HB Allen Charitable Trust and the Cambridge Eye Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Previous studies have demonstrated that intravitreal delivery of brain-derived neurotrophic factor (BDNF) by injection of recombinant protein or by gene therapy can alleviate retinal ganglion cell (RGC) loss after optic nerve injury. BDNF gene therapy can improve RGC survival in experimental models of glaucoma, the leading cause of irreversible blindness worldwide. However, the therapeutic efficacy of BDNF supplementation alone is time limited at least in part due to BDNF receptor downregulation. Tropomyosin-related receptor kinase-B (TrkB) downregulation has been reported in many neurological diseases including glaucoma, potentially limiting the effect of sustained or repeated BDNF delivery.<\/jats:p>\n                  <jats:p>Here, we characterize a novel adeno-associated virus (AAV) gene therapy (AAV2 TrkB-2A-mBDNF) that not only increases BDNF production but also improves long-term neuroprotective signaling by increasing expression of the BDNF receptor (TrkB) within the inner retina. This approach leads to significant and sustained elevation of survival signaling pathways ERK and AKT within RGCs over 6 months and avoids the receptor downregulation which we observe with treatment with AAV2 BDNF alone. We validate the neuroprotective efficacy of AAV2 TrkB-2A-mBDNF in a mouse model of optic nerve injury, where it outperforms conventional AAV2 BDNF or AAV2 TrkB therapy, before showing powerful proof of concept neuroprotection of RGCs and axons in a rat model of chronic intraocular pressure (IOP) elevation. We also show that there are no adverse effects of the vector on retinal structure or function as assessed by histology and electroretinography in young or aged animals. Further studies are underway to explore the potential of this vector as a candidate for progression into clinical studies to protect RGCs in patients with glaucoma and progressive visual loss despite conventional IOP-lowering treatment.<\/jats:p>","DOI":"10.1038\/s41419-018-1041-8","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T10:47:39Z","timestamp":1537958859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":167,"title":["Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor\/tropomyosin-related kinase receptor-B signaling"],"prefix":"10.1038","volume":"9","author":[{"given":"Andrew","family":"Osborne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasneem Z.","family":"Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalana","family":"Songra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda C.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Y. X.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Widdowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"1041_CR1","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","volume":"390","author":"J Jonas","year":"2017","unstructured":"Jonas, J. et al. Glaucoma. Lancet 390, 2183\u20132193 (2017).","journal-title":"Lancet"},{"key":"1041_CR2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ophtha.2005.06.020","volume":"112","author":"S Miglior","year":"2005","unstructured":"Miglior, S. et al. Results of the European Glaucoma Prevention Study. Ophthalmology 112, 366\u2013375 (2005).","journal-title":"Ophthalmology"},{"key":"1041_CR3","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","volume":"385","author":"D Garway-Heath","year":"2015","unstructured":"Garway-Heath, D. et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 385, 1295\u20131304 (2015).","journal-title":"Lancet"},{"key":"1041_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ophtha.2015.09.027","volume":"123","author":"J Caprioli","year":"2016","unstructured":"Caprioli, J. et al. Trabeculectomy can improve long-term visual function in glaucoma. Ophthalmology 123, 117\u2013128 (2016).","journal-title":"Ophthalmology"},{"key":"1041_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1755-3768.2012.02492.x","volume":"91","author":"A Heijl","year":"2013","unstructured":"Heijl, A., Buchholz, P., Norrgren, G. & Bengtsson, B. Rates of visual field progression in clinical glaucoma care. Acta Ophthalmol. 91, 406\u2013412 (2013).","journal-title":"Acta Ophthalmol."},{"key":"1041_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ophtha.2013.09.003","volume":"121","author":"M Malihi","year":"2014","unstructured":"Malihi, M., Moura Filho, E., Hodge, D. & Sit, A. Long-term trends in glaucoma-related blindness in Olmsted County, Minnesota. Ophthalmology 121, 134\u2013141 (2014).","journal-title":"Ophthalmology"},{"key":"1041_CR7","doi-asserted-by":"publisher","first-page":"e0151010","DOI":"10.1371\/journal.pone.0151010","volume":"11","author":"L Rossetti","year":"2016","unstructured":"Rossetti, L. et al. Correction: Blindness and glaucoma: a multicenter data review from 7 academic eye clinics. PLoS One 11, e0151010 (2016).","journal-title":"PLoS One"},{"key":"1041_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0896-6273(93)90306-C","volume":"10","author":"N Ip","year":"1993","unstructured":"Ip, N. et al. Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron 10, 137\u2013149 (1993).","journal-title":"Neuron"},{"key":"1041_CR9","doi-asserted-by":"publisher","first-page":"25296","DOI":"10.1074\/jbc.272.40.25296","volume":"272","author":"M Haniu","year":"1997","unstructured":"Haniu, M. et al. Interactions between brain-derived neurotrophic factor and the TRKB receptor. Identification of two ligand binding domains in soluble TRKB by affinity separation and chemical cross-linking. J. Biol. Chem. 272, 25296\u201325303 (1997).","journal-title":"J. Biol. Chem."},{"key":"1041_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev.biochem.72.121801.161629","volume":"72","author":"E Huang","year":"2003","unstructured":"Huang, E. & Reichardt, L. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609\u2013642 (2003).","journal-title":"Annu. Rev. Biochem."},{"key":"1041_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/0006-8993(93)90695-J","volume":"602","author":"J Mey","year":"1993","unstructured":"Mey, J. & Thanos, S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res. 602, 304\u2013317 (1993).","journal-title":"Brain Res."},{"key":"1041_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.exer.2009.02.015","volume":"89","author":"G Parrilla-Reverter","year":"2009","unstructured":"Parrilla-Reverter, G. et al. Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study. Exp. Eye Res. 89, 32\u201341 (2009).","journal-title":"Exp. Eye Res."},{"key":"1041_CR13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/dneu.20765","volume":"70","author":"A Yoshii","year":"2010","unstructured":"Yoshii, A. & Constantine-Paton, M. Post-synaptic BDNF-TrkB signalling in synapse maturation, plasticity and disease. Dev. Neurobiol. 70, 304\u2013322 (2010).","journal-title":"Dev. Neurobiol."},{"key":"1041_CR14","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3892\/mmr.2013.1433","volume":"7","author":"Y Liu","year":"2013","unstructured":"Liu, Y., Tao, L., Zhao, Y. & Xu, X. BDNF protects retinal neurons from hyperglycemia through the TrkB\/ERK\/MAPK pathway. Mol. Med. Rep. 7, 1773\u20131778 (2013).","journal-title":"Mol. Med. Rep."},{"key":"1041_CR15","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3390\/ijms17091584","volume":"17","author":"A Kimura","year":"2016","unstructured":"Kimura, A., Namekata, K., Guo, X., Harada, C. & Harada, T. Neuroprotection, growth factors and BDNF-TrkB signalling in retinal degeneration. Int. J. Mol. Sci. 17, 1584 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"1041_CR16","first-page":"3460","volume":"41","author":"H Quigley","year":"2000","unstructured":"Quigley, H. et al. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest. Ophthalmol. Vis. Sci. 41, 3460\u20133466 (2000).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"Suppl 1","key":"1041_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1463-5224.2007.00504.x","volume":"10","author":"S Iwabe","year":"2007","unstructured":"Iwabe, S., Moreno-Mendoza, N., Trigo-Tavera, F., Crowder, C. & Garcia-Sanchez, G. Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma. Vet. Ophthalmol. 10(Suppl 1), 12\u201319 (2007).","journal-title":"Vet. Ophthalmol."},{"key":"1041_CR18","first-page":"764","volume":"41","author":"M Pease","year":"2000","unstructured":"Pease, M., McKinnon, S., Quigley, H., Kerrigen-Baumrind, L. & Zack, D. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest. Ophthmol. Vis. Sci. 41, 764\u2013774 (2000).","journal-title":"Invest. Ophthmol. Vis. Sci."},{"key":"1041_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.optm.2008.09.014","volume":"80","author":"A Ghaffariyeh","year":"2009","unstructured":"Ghaffariyeh, A. et al. Brain-derived neurotrophic factor in patients with normal-tension glaucoma. Optometry 80, 635\u2013638 (2009).","journal-title":"Optometry"},{"key":"1041_CR20","doi-asserted-by":"publisher","first-page":"e0168565","DOI":"10.1371\/journal.pone.0168565","volume":"12","author":"F Oddone","year":"2017","unstructured":"Oddone, F. et al. Exploring serum levels of brain derived neuroptrophic factor and nerve growth factor across glaucoma stages. PLoS One 12, e0168565 (2017).","journal-title":"PLoS One"},{"key":"1041_CR21","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.bbadis.2014.05.026","volume":"1842","author":"V Gupta","year":"2014","unstructured":"Gupta, V. et al. BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma. Biochim. Biophys. Acta 1842, 1567\u20131578 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"1041_CR22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00417-018-3923-y","volume":"256","author":"M Uzel","year":"2018","unstructured":"Uzel, M. et al. The effect of trabeculectomy on serum brain-derived neurotrophic factor levels in primary open-angle glaucoma. Graefes Arch. Clin. Exp. Ophthalmol. 256, 1173\u20131178 (2018).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"1041_CR23","first-page":"966","volume":"42","author":"H Chen","year":"2001","unstructured":"Chen, H. & Weber, A. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest. Ophthalmol. Vis. Sci. 42, 966\u2013974 (2001).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1041_CR24","doi-asserted-by":"publisher","first-page":"e115579","DOI":"10.1371\/journal.pone.0115579","volume":"9","author":"L Domenici","year":"2014","unstructured":"Domenici, L. et al. Rescue of retinal function by BDNF in a mouse model of glaucoma. PLoS One 9, e115579 (2014).","journal-title":"PLoS One"},{"key":"1041_CR25","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1167\/iovs.02-1332","volume":"44","author":"K Martin","year":"2003","unstructured":"Martin, K. et al. Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 44, 4257\u20134365 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1041_CR26","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1167\/iovs.11-8484","volume":"53","author":"R Ren","year":"2012","unstructured":"Ren, R., Li, Y., Liu, Z., Liu, K. & He, S. Long-term rescue of rat retinal ganglion cells and visual function by AAV-mediated BDNF expression after acute elevation of intraocular pressure. Invest. Ophthalmol. Vis. Sci. 53, 1003\u20131011 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1041_CR27","first-page":"816","volume":"22","author":"T Igarashi","year":"2016","unstructured":"Igarashi, T. et al. Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation. Mol. Vis. 22, 816\u2013826 (2016).","journal-title":"Mol. Vis."},{"key":"1041_CR28","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0042-6989(97)00341-6","volume":"38","author":"D Clarke","year":"1998","unstructured":"Clarke, D., Bray, G. & Aguayo, A. Prolonged administration of NT-4\/5 fails to rescue most axotomized retinal ganglion cells in adult rats. Vision Res. 38, 1517\u20131524 (1998).","journal-title":"Vision Res."},{"key":"1041_CR29","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1073\/pnas.95.7.3978","volume":"95","author":"A Di Polo","year":"1998","unstructured":"Di Polo, A., Aigner, L., Dunn, R., Bray, G. & Aguayo, A. Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected M\u00fcller cells temporarily rescues injured retinal ganglion cells. Proc. Natl. Acad. Sci. U.S.A. 95, 3978\u20133983 (1998).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"1041_CR30","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1460-9568.1996.tb01290.x","volume":"8","author":"L Frank","year":"1996","unstructured":"Frank, L., Ventimiglia, R., Anderson, K., Lindsay, R. & Rudge, J. BDNF down-regulates neurotrophin responsiveness, TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons. Eur. J. Neurosci. 8, 1220\u20131230 (1996).","journal-title":"Eur. J. Neurosci."},{"key":"1041_CR31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0306-4522(96)00616-1","volume":"78","author":"B Knusel","year":"1997","unstructured":"Knusel, B. et al. Ligand-induced down-regulation of TrkB messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons. Neuroscience 78, 851\u2013862 (1997).","journal-title":"Neuroscience"},{"key":"1041_CR32","doi-asserted-by":"publisher","first-page":"8982","DOI":"10.1074\/jbc.275.12.8982","volume":"275","author":"M Sommerfeld","year":"2000","unstructured":"Sommerfeld, M., Schweigreiter, R., Barde, Y. & Hoppe, E. Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB. J. Biol. Chem. 275, 8982\u20138990 (2000).","journal-title":"J. Biol. Chem."},{"key":"1041_CR33","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1126\/science.1065057","volume":"294","author":"R Lee","year":"2001","unstructured":"Lee, R., Kermani, P., Teng, K. & Hempstead, B. Regulation of cell survival by secreted proneurotrophins. Science 294, 1945\u20131948 (2001).","journal-title":"Science"},{"key":"1041_CR34","doi-asserted-by":"publisher","first-page":"21205","DOI":"10.1074\/jbc.M114.563403","volume":"289","author":"B Kraemer","year":"2014","unstructured":"Kraemer, B. et al. A role for the p75 neurotrophin receptor in axonal degeneration and apoptosis induced by oxidative stress. J. Biol. Chem. 289, 21205\u201321216 (2014).","journal-title":"J. Biol. Chem."},{"key":"1041_CR35","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1523\/JNEUROSCI.5123-04.2005","volume":"25","author":"H Teng","year":"2005","unstructured":"Teng, H. et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J. Neurosci. 25, 5455\u20135463 (2005).","journal-title":"J. Neurosci."},{"key":"1041_CR36","doi-asserted-by":"publisher","first-page":"39392","DOI":"10.1074\/jbc.M110.147801","volume":"285","author":"Y Bai","year":"2010","unstructured":"Bai, Y. et al. Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism. J. Biol. Chem. 285, 39392\u201339400 (2010).","journal-title":"J. Biol. Chem."},{"key":"1041_CR37","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1089\/hum.2017.069","volume":"29","author":"A Osborne","year":"2018","unstructured":"Osborne, A., Wang, A., Tassoni, A., Widdowson, P. & Martin, K. R. Design of a novel gene therapy construct to achieve sustained brain-derived neurotrophic factor signaling in neurons. Hum. Gene Ther. 29, 828\u2013841 (2018).","journal-title":"Hum. Gene Ther."},{"key":"1041_CR38","first-page":"402","volume":"43","author":"H Levkovitch-Verbin","year":"2002","unstructured":"Levkovitch-Verbin, H. et al. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest. Ophthalmol. Vis. Sci. 43, 402\u2013410 (2002).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1041_CR39","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/nprot.2010.128","volume":"5","author":"N Marina","year":"2010","unstructured":"Marina, N., Bull, N. & Martin, K. A semiautomated targeted sampling method to assess optic nerve axonal loss in a rat model of glaucoma. Nat. Protoc. 5, 1642\u20131651 (2010).","journal-title":"Nat. Protoc."},{"key":"1041_CR40","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.1167\/iovs.09-3814","volume":"50","author":"Y Kong","year":"2009","unstructured":"Kong, Y., Crowston, J., Vingrys, A., Trounce, I. & Bui, V. Functional changes in the retina during and after acute intraocular pressure elevation in mice. Invest. Ophthalmol. Vis. Sci. 50, 5732\u20135740 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1041_CR41","doi-asserted-by":"publisher","first-page":"12564","DOI":"10.1073\/pnas.0914191107","volume":"107","author":"A Burgess","year":"2010","unstructured":"Burgess, A. et al. Loss of human Greatwall results in G2 arrest and multiple mitotic defects due to deregulation of the cyclin B-Cdc2\/PP2A balance. Proc. Natl. Acad. Sci. U.S.A. 107, 12564\u201312569 (2010).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"1041_CR42","doi-asserted-by":"crossref","unstructured":"Lambert, W. et al. Oral delivery of a synthetic sterol reduces axonopathy and inflammation in a rodent model of glaucoma. Front. Neurosci. 11, 45 (2017).","DOI":"10.3389\/fnins.2017.00045"},{"key":"1041_CR43","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1002\/stem.2095","volume":"33","author":"A Tassoni","year":"2015","unstructured":"Tassoni, A., Gutteridge, A., Barber, A., Osborne, A. & Martin, K. Molecular mechanisms mediating retinal reactive gliosis following bone marrow mesenchymal stem cell transplantation. Stem Cells 33, 3006\u20133016 (2015).","journal-title":"Stem Cells"},{"key":"1041_CR44","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1073\/pnas.91.5.1632","volume":"91","author":"S Mansour-Robaey","year":"1994","unstructured":"Mansour-Robaey, S., Clarke, D., Wang, Y., Bray, G. & Aguayo, A. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc. Natl. Acad. Sci. U.S.A. 91, 1632\u20131636 (1994).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"1041_CR45","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","volume":"23","author":"S Gin\u00e9s","year":"2006","unstructured":"Gin\u00e9s, S. et al. Reduced expression of the TrkB receptor in Huntington\u2019s disease mouse models and in human brain. Eur. J. Neurosci. 23, 649\u2013658 (2006).","journal-title":"Eur. J. Neurosci."},{"key":"1041_CR46","doi-asserted-by":"publisher","first-page":"e0142067","DOI":"10.1371\/journal.pone.0142067","volume":"10","author":"E Dekeyster","year":"2015","unstructured":"Dekeyster, E. et al. Tackling glaucoma from within the brain: an unfortunate interplay of BDNF and TrkB. PLoS One 10, e0142067 (2015).","journal-title":"PLoS One"},{"key":"1041_CR47","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.neuroscience.2004.11.027","volume":"131","author":"K Spalding","year":"2005","unstructured":"Spalding, K., Cui, Q. & Harvey, A. Retinal ganglion cell neurotrophin receptor levels and trophic requirements following target ablation in the neonatal rat. Neuroscience 131, 387\u2013395 (2005).","journal-title":"Neuroscience"},{"key":"1041_CR48","doi-asserted-by":"publisher","first-page":"41839","DOI":"10.1074\/jbc.M402872200","volume":"279","author":"B Srinivasan","year":"2004","unstructured":"Srinivasan, B., Roque, C., Hempstead, B., Al-Ubaidi, M. & Roque, R. Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J. Biol. Chem. 279, 41839\u201341845 (2004).","journal-title":"J. Biol. Chem."},{"key":"1041_CR49","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.mcn.2008.12.005","volume":"40","author":"F Lebrun-Julien","year":"2009","unstructured":"Lebrun-Julien, F., Morquette, B., Douillette, A., Saragovi, H. & Di Polo, A. Inhibition of p75(NTR) in glia potentiates TrkA-mediated survival of injured retinal ganglion cells. Mol. Cell. Neurosci. 40, 410\u2013420 (2009).","journal-title":"Mol. Cell. Neurosci."},{"key":"1041_CR50","first-page":"606","volume":"15","author":"H Quigley","year":"1976","unstructured":"Quigley, H. & Anderson, D. The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve. Invest. Ophthalmol. Vis. Sci. 15, 606\u2013616 (1976).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1041_CR51","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1523\/JNEUROSCI.22-10-03977.2002","volume":"22","author":"L Cheng","year":"2002","unstructured":"Cheng, L., Sapieha, P., Kittlerova, P., Hauswith, W. & Di Polo, A. TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J. Neurosci. 22, 3977\u20133986 (2002).","journal-title":"J. Neurosci."},{"key":"1041_CR52","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1167\/iovs.09-4450","volume":"51","author":"Y Hu","year":"2010","unstructured":"Hu, Y., Cho, S. & Goldberg, J. Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 51, 1747\u20131754 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1041_CR53","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","volume":"31","author":"M Almasieh","year":"2012","unstructured":"Almasieh, M., Wilson, A., Morquette, B., Cueva Vargas, J. & Di Polo, A. The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retin. Eye Res. 31, 152\u2013181 (2012).","journal-title":"Prog. Retin. Eye Res."},{"key":"1041_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1190","volume":"2","author":"C Harada","year":"2011","unstructured":"Harada, C. et al. Glia- and neuron-specific functions of TrkB signalling during retinal degeneration and regeneration. Nat. Commun. 2, 189 (2011).","journal-title":"Nat. Commun."},{"key":"1041_CR55","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1016\/j.ajpath.2015.08.005","volume":"185","author":"C Harada","year":"2015","unstructured":"Harada, C. et al. TrkB signaling in retinal glia stimulates neuroprotection after optic nerve injury. Am. J. Pathol. 185, 3238\u20133247 (2015).","journal-title":"Am. J. Pathol."},{"key":"1041_CR56","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/sj.gt.3302791","volume":"13","author":"S Leaver","year":"2006","unstructured":"Leaver, S. et al. AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells. Gene Ther. 13, 1328\u20131341 (2006).","journal-title":"Gene Ther."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1041-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T15:56:33Z","timestamp":1720626993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1041-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["1041"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1041-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"assertion":[{"value":"6 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.S.W. and K.R.M. have a financial interest in Quethera Ltd, a company working to develop gene therapy approaches to neurodegenerative diseases. A.O., K.H., and K.R.M. have received grant support from Quethera Ltd. T.Z.K., L.S., A.C.B., and G.Y.X.K. have no disclosures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1007"}}